Showing results (361-370 of 602) with videos related to
Sort By:
Pageof 61
Journal of Neurology|June 30, 2009
Delayed onset of the diurnal melatonin rise in patients with Huntington's diseaseN Ahmad Aziz, Hanno Pijl, Marijke Frölich, et al.European Journal of Neurology|October 23, 2009
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's diseaseN A Aziz, H Pijl, M Frölich, et al.The British Journal of Cancer. Supplement|July 1, 1990
Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and manH J Haisma, M A Kessel, C Silva, et al.Brain Pathology (Zurich, Switzerland)|April 15, 2006
The cerebral beta-amyloid angiopathies: hereditary and sporadicSandy X Zhang-Nunes, Marion L C Maat-Schieman, Sjoerd G van Duinen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 11, 2010
Late-onset Huntington disease with intermediate CAG repeats: true or false?Justus L Groen, Rob M A de Bie, Elisabeth M J Foncke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.Journal of Neuroscience Research|July 14, 2007
Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch typeKazuchika Nishitsuji, Takami Tomiyama, Kenichi Ishibashi, et al.Molecular and Cellular Neurosciences|July 5, 2005
Mutant huntingtin represses CBP, but not p300, by binding and protein degradationShu-Yan Cong, Barry A Pepers, Bernd O Evert, et al.Molecular and Cellular Neurosciences|February 4, 2006
Mutant huntingtin represses CBP, but not p300, by binding and protein degradationShu-Yan Cong, Barry A Pepers, Bernd O Evert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.Pageof 61